Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    Sorry, I don't understand. Please try again

    1. Home/
    2. News/
    3. Caring & giving/
    4. 7 facts you need to know about veteran suicide—and how you can #BeThere for service members
    CTA Veteran Suicide PSA photo

    7 facts you need to know about veteran suicide—and how you can #BeThere for service members

    In honor of Suicide Prevention Month, learn why Johnson & Johnson is part of a campaign to help prevent the growing problem of suicide among service members who’ve returned to civilian life.

    Each day, 20 veterans die from suicide in the U.S.

    Johnson & Johnson has a rich history of supporting service members, which is why it has partnered with the U.S. Department of Veterans Affairs (VA) to launch the #BeThere campaign aimed at raising awareness of veteran suicide.

    The goal: help veterans and service members in need of support and resources before it’s too late.

    “As one of the world’s largest healthcare companies, with a 115-year history of working with the military and veterans, we believe we have a responsibility to help address the issue,” says former U.S. Army captain Courtney Billington, President, Neurosciences, Janssen Pharmaceuticals, part of the Johnson & Johnson family of companies. “By working with like-minded partners, Johnson & Johnson is uniquely positioned to reach, engage and empower the public to support the heroes in our communities.”

    We take a deeper look at the crisis—and spotlight what you can do to help make a difference.

    Infographic: 7 Facts You Need to Know About Veteran Suicide—and How You Can #BETHERE

    More from Johnson & Johnson

    Johnson & Johnson named to The Wall Street Journal’s 2026 Best Companies for the Future list

    The company’s ability to evolve as it tackles the world’s toughest health challenges has helped Johnson & Johnson earn its spot as the top-ranked healthcare company on the list.

    Striving for a cure for multiple myeloma: What HCPs need to know

    Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer.

    The future of immunology

    Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.